Hikma Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
09 Aug 24 | Sell€1,035,608 | Bassam Wael Kanaan | Individual | 45,000 | €23.67 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
State or Government | 75,838 | 0.0342% |
Employee Share Scheme | 585,575 | 0.264% |
Individual Insiders | 4,958,698 | 2.24% |
General Public | 33,726,905 | 15.2% |
Private Companies | 60,799,262 | 27.4% |
Institutions | 121,601,297 | 54.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
60,000,000 | €1.4b | 0% | no data | |||
12,279,824 | €288.1m | -0.78% | no data | |||
7,697,347 | €180.6m | 0.99% | no data | |||
4,784,387 | €112.3m | 0% | 0.35% | |||
4,509,759 | €105.8m | 0% | 0.24% | |||
3,127,566 | €73.4m | 4% | 0.09% | |||
3,001,865 | €70.4m | 0% | 0.17% | |||
2,964,513 | €69.6m | 11.9% | 0.04% | |||
2,884,622 | €67.7m | 0% | 0.25% | |||
2,680,705 | €62.9m | -4.93% | 0.03% | |||
2,661,342 | €62.4m | 0% | 0.01% | |||
2,410,009 | €56.5m | -0.78% | 0.03% | |||
2,365,442 | €55.5m | -0.09% | no data | |||
2,316,177 | €54.3m | 29.8% | 0.15% | |||
2,261,074 | €53.1m | 6.6% | 0.02% | |||
2,235,404 | €52.5m | -0.56% | 0.01% | |||
1,960,235 | €46.0m | -3.06% | no data | |||
1,826,030 | €42.8m | -7.09% | 0.01% | |||
1,817,321 | €42.6m | 0% | 0.01% | |||
1,740,300 | €40.8m | 2.32% | 0.02% | |||
1,711,373 | €40.2m | -2.19% | no data | |||
1,703,279 | €40.0m | 8.64% | 0.08% | |||
1,700,611 | €39.9m | 0.51% | 0.02% | |||
1,648,490 | €38.7m | -16.9% | 0.13% | |||
1,627,349 | €38.2m | 0.4% | 0.26% |